What is the recommended dosing for Flagyl (metronidazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flagyl (Metronidazole) Dosing

The recommended dosing for Flagyl varies significantly by indication: for trichomoniasis use 2 g orally as a single dose or 500 mg twice daily for 7 days; for bacterial vaginosis use 500 mg orally twice daily for 7 days; for amebiasis use 500-750 mg orally three times daily for 5-10 days; and for anaerobic bacterial infections use 500 mg (7.5 mg/kg) orally every 6 hours for 7-10 days, though metronidazole is now second-line for C. difficile infection. 1, 2

Trichomoniasis Dosing

Single-dose regimen (preferred for compliance):

  • Metronidazole 2 g orally as a single dose achieves 90-95% cure rates 1
  • This regimen ensures compliance, especially when directly observed 1
  • Results in higher serum levels that can reach fetal circulation, so avoid in pregnancy 1, 2

Alternative multi-day regimen:

  • Metronidazole 500 mg orally twice daily for 7 days 1
  • Or 250 mg orally three times daily for 7 days 1, 2
  • May achieve slightly higher cure rates and minimize reinfection by covering the treatment period for sexual contacts 1

For pregnant patients:

  • Use 250 mg orally three times daily for 7 days (lower dose to minimize fetal exposure) 1
  • Avoid single-dose 2 g regimen due to higher fetal drug levels 1, 2
  • Do not treat during first trimester 2

Bacterial Vaginosis Dosing

  • Metronidazole 500 mg orally twice daily for 7 days 1
  • Alternative: 250 mg orally three times daily for 7 days 1
  • Single-dose 2 g regimen is less effective for BV than for trichomoniasis 1
  • Topical metronidazole gel is not recommended for trichomoniasis but can be used for BV 1

Amebiasis Dosing

Acute intestinal amebiasis (acute amebic dysentery):

  • Adults: 750 mg orally three times daily for 5-10 days 2

Amebic liver abscess:

  • Adults: 500-750 mg orally three times daily for 5-10 days 2

Pediatric patients:

  • 35-50 mg/kg/24 hours divided into three doses for 10 days 2

Anaerobic Bacterial Infections Dosing

  • Adults: 7.5 mg/kg orally every 6 hours (approximately 500 mg for a 70 kg adult) 2
  • Maximum 4 g per 24-hour period 2
  • Usual duration: 7-10 days 2
  • Bone/joint, lower respiratory tract, and endocardium infections may require longer treatment 2

Once-daily alternative for serious intraabdominal/pelvic infections:

  • Metronidazole 1 g IV every 24 hours appears as efficacious as multiple daily dosing for B. fragilis infections 3
  • Pharmacokinetic studies demonstrate activity for 12-24 hours after 1 g dose with post-antibiotic effect extending beyond 3 hours 4

C. difficile Infection Dosing (Now Second-Line)

Critical update: Metronidazole is no longer first-line for C. difficile infection 1, 5, 6

First-line therapy:

  • Vancomycin 125 mg orally four times daily for 10 days OR fidaxomicin 200 mg twice daily for 10 days 1, 5, 6

Metronidazole use only when vancomycin/fidaxomicin unavailable:

  • For non-severe CDI only: 500 mg orally three times daily for 10 days 1, 5, 6
  • Cure rates inferior to vancomycin (84% vs 97% overall; 76% vs 97% in severe disease) 6
  • Never use for severe CDI 1, 6

Fulminant CDI:

  • Vancomycin 500 mg orally four times daily PLUS IV metronidazole 500 mg every 8 hours 1, 5, 6

Giardiasis Dosing

  • Metronidazole 250 mg orally three times daily for 5-7 days 6
  • Note: Tinidazole is now preferred first-line agent 6
  • Expect gastrointestinal side effects including metallic taste 5, 6

Special Population Adjustments

Elderly patients:

  • Monitor serum levels as pharmacokinetics may be altered 2, 7
  • Reduced renal excretion of parent drug and hydroxy metabolite 7
  • Consider dosage adjustment based on monitoring 2

Severe hepatic disease:

  • Reduce doses below usual recommendations 2
  • Metronidazole accumulates due to slow metabolism 2, 7
  • Close monitoring of plasma levels and toxicity recommended 2

Renal failure:

  • No specific dose reduction needed for parent drug 2, 7
  • Metabolites accumulate but no documented toxicity 7
  • Hemodialysis removes substantial amounts; peritoneal dialysis has limited effect 7

Critical Safety Warnings

Neurotoxicity risk:

  • Avoid repeated or prolonged courses due to cumulative and potentially irreversible neurotoxicity 1, 6
  • For recurrent CDI, never use metronidazole—switch to vancomycin tapered/pulsed regimens 5, 6

Treatment failure management:

  • If initial regimen fails, re-treat with 500 mg twice daily for 7 days 1
  • For repeated failures, use 2 g once daily for 3-5 days 1
  • Consider susceptibility testing for culture-documented resistant infections 1

Drug interactions:

  • Avoid alcohol (disulfiram-like reaction) 8
  • Monitor warfarin and phenytoin levels 8

Monitoring:

  • Total and differential leukocyte counts before and after re-treatment 2
  • Allow 4-6 weeks between repeat courses 2
  • Reconfirm infection presence before re-treatment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metronidazole Dosing for C. difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole Dosing for Infectious Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Metronidazole].

Annales de dermatologie et de venereologie, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.